Aeris Therapeutics, Inc.
Aeris Therapeutics, Inc. (Aeris) is a privately held medical device company. It is principally engaged in the design, development, manufacture and marketing of therapeutic systems and devices used for the treatment of patients with emphysema and other lung diseases. Aeris has designed a system known as The AeriSeal system used for treatment of both homogeneous and heterogeneous emphysema. The company develops the Biologic Lung Volume Reduction (BLVR) System to achieve lung volume reduction without surgery and its attendant risks. BLVR is a minimally invasive treatment alternative for patients with advanced emphysema who currently have limited treatment options. Currently, the company committed to invest in research and development and fueling innovation, delivering novel products. Aeris is headquartered in Massachusetts, the US.